Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marcus Ruscetti

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Nature cancer

Science (New York, N.Y.)

Molecular cancer therapeutics

Cancer discovery

Memorial Sloan-Kettering Cancer Center

UCLA (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Memorial Sloan-Kettering Cancer Center Jul 1o 2015

United States

Postdoctoral Researcher :: Cancer Biology and Genetics

Education History

UCLA

United States

PHD :: Molecular and Medical Pharmacology

Publications

Loretah Chibaya, Katherine C Murphy, Kelly D DeMarco, Sneha Gopalan, Haibo Liu, Chaitanya N Parikh, Yvette Lopez-Diaz, Melissa Faulkner, Junhui Li, John P Morris, Yu-Jui Ho, Sachliv K Chana, Janelle Simon, Wei Luan, Amanda Kulick, Elisa de Stanchina, Karl Simin, Julie Lihua Zhu, Thomas G Fazzio, Scott W Lowe, Marcus Ruscetti
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nature cancer (2023)
Loretah Chibaya, Katherine C Murphy, Kelly D DeMarco, Sneha Gopalan, Haibo Liu, Chaitanya N Parikh, Yvette Lopez-Diaz, Melissa Faulkner, Junhui Li, John P Morris, Yu-Jui Ho, Sachliv K Chana, Janelle Simon, Wei Luan, Amanda Kulick, Elisa de Stanchina, Karl Simin, Julie Lihua Zhu, Thomas G Fazzio, Scott W Lowe, Marcus Ruscetti
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nature cancer (2023)
Loretah Chibaya, Katherine C Murphy, Kelly D DeMarco, Sneha Gopalan, Haibo Liu, Chaitanya N Parikh, Yvette Lopez-Diaz, Melissa Faulkner, Junhui Li, John P Morris, Yu-Jui Ho, Sachliv K Chana, Janelle Simon, Wei Luan, Amanda Kulick, Elisa de Stanchina, Karl Simin, Julie Lihua Zhu, Thomas G Fazzio, Scott W Lowe, Marcus Ruscetti
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nature cancer (2023)
Loretah Chibaya, Christina F Lusi, Kelly D DeMarco, Griffin I Kane, Meghan L Brassil, Chaitanya N Parikh, Katherine C Murphy, Junhui Li, Tiana E Naylor, Julia Cerrutti, Jessica Peura, Jason R Pitarresi, Julie Lihua Zhu, Katherine A Fitzgerald, Prabhani U Atukorale, Marcus Ruscetti
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer. bioRxiv : the preprint server for biology (2023)
Josef Leibold, Marcus Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou, Wassim Abida, Judith Feucht, Teng Han, Francisco M Barriga, Kaloyan M Tsanov, Leah B Zamechek, Amanda Kulick, Corina Amor, Sha Tian, Katarzyna Rybczyk, Nelson R Salgado, Francisco J Sánchez Rivera, Philip A Watson, Elisa de Stanchina, John E Wilkinson, Lukas E Dow, Cory Abate-Shen, Charles L Sawyers, Scott W Lowe
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis. Cancer discovery 10 (7) (2020)
Marcus Ruscetti, Josef Leibold, Matthew J Bott, Myles Fennell, Amanda Kulick, Nelson R Salgado, Chi-Chao Chen, Yu-Jui Ho, Francisco J Sanchez-Rivera, Judith Feucht, Timour Baslan, Sha Tian, Hsuan-An Chen, Paul B Romesser, John T Poirier, Charles M Rudin, Elisa de Stanchina, Eusebio Manchado, Charles J Sherr, Scott W Lowe
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science (New York, N.Y.) 362 (6421) (2019)
Yongkang Zou, Zhi Qi, Weilong Guo, Liuzhen Zhang, Marcus Ruscetti, Tanu Shenoy, Ningshu Liu, Hong Wu
Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439. Molecular cancer therapeutics 17 (10) (2018)

Marcus Ruscetti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marcus Ruscetti